Automated Reinforcement Management Systems, Phase II
Washington State University
125 participants
Jun 7, 2024
INTERVENTIONAL
Conditions
Summary
The Automated Reinforcement Management Systems Phase II (ARMS II) study is a phase II trial is a randomized controlled, non-medicated assisted trial to determine the effectiveness of Contingency Management (CM) treatment for reducing alcohol drinking among adults who want to quit or reduce their alcohol consumption.
Eligibility
Inclusion Criteria6
- Age 18-70 years
- Have consumed 3 or more drinks in once occasion 4 or more times in the previous 30 days 3
- Have the ability to read and speak English
- Have the ability to provide written informed consent
- Have a breath alcohol value of 0.00 during informed consent
- Owns a smartphone with an active service provider that is compatible with the study application.
Exclusion Criteria7
- Severe alcohol use disorder that our medical staff deems too risky for safe participation;
- Significant risk of dangerous alcohol withdrawal, defined as history of seizure due to alcohol withdrawal in the last 12 months and/or expression of concern by the participant about dangerous withdrawal
- Anyone aged 71 or older.
- Anyone with a suicide attempt in the last 2 years.
- Individuals who express concern regarding dangerous withdrawal or who exhibit dangerous withdrawal symptoms.
- Individuals who do not test BrAC = 0.00 on the breathalyzer during the baseline visit.
- Any other condition that investigators determine a medical or psychiatric condition that would compromise safe study participation.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants in the contingent group will be rewarded on an incrementally increasing scale for submitting consecutive breathalyzer samples that are 0.00%. For every day this target is met, the participant will receive an increase in reward until a daily cap is reached. If a day contains at least one sample where the target is not met, the participant will not be paid for that day, and the amount will reset. The participant will have the opportunity to earn on this scale throughout the duration of the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06456905